- Dr. rer. nat. Andreas Hartlep
Chief Executive OfficerDr. Hartlep is CEO at cerbomed GmbH since in April 2010. He joined cerbomed in 2009 as CTO. He has over 12 years experience in leadership and senior management roles in medical device technology, R&D and clinical operations including the development of IGS and robotic products. Prior to his last position as Executive Director R&D for Prosurgics, Wycombe, UK, a Start-Up company specializing in image-guided surgical robotics, Dr. Hartlep was Director Clinical Operations with Timaq Medical Imaging, Zurich, Switzerland, an innovative clinical trial service company specializing in imaging aspects for both pharmaceutical and medical device companies. Before this, Dr. Hartlep had spent several years with Brainlab Inc., Munich, Germany, where he took increasing responsibilities as Project Manager, Senior Project Manager and Research Director mainly in the areas of neuroscience and imaging. Dr. Hartlep holds a degree in Physics and Medical Physics from the University of Heidelberg, Germany, and acquired his Ph.D. with the German Cancer Research Institut (DKFZ) in Heidelberg, Germany.
- Wolfgang Grillenberger
Chief Commercial OfficerWolfgang Grillenberger joined cerbomed GmbH in July 2013 and serves as Chief Commercial Officer. Mr. Grillenberger has more than 15 years consultative and practical experience in the management of medical devices and biotech companies. His core competencies are strategy and organizational development, marketing and sales, business development and internationalization.
He participated at the launch of 3 high tech-start ups and
5 subsidiaries in 6 European countries. Mr. Grillenberger was Business Development Manager of the year in 2006.
- Dr. Robert Pfeffer
Chief Financial OfficerDr. Pfeffer is Head of Finance at cerbomed GmbH since October 2008. He began his 10 years banking career in internal traineeships with the Sparkasse Finanzgruppe in Erlangen as well as the Bayrische Landesbank (BayernLB) in New York focusing on Corporate Finance and Internal Audit. After several years of Corporate Client Consultant, he specialized during five years in consulting Start Up companies and managed them through different stages of their development. For many years, he also acted as member of several juries for Start-Up and Entrepreneurship competitions. Dr. Pfeffer holds a degree in Business Administration as well as in Economics, and a PhD.
- Thomas Zschaeck
Director Research & DevelopmentThomas Zschaeck joined cerbomed in early 2012. He has over 20 years experience in the telecommunications industries, working at Philips Kommunikations Industrie and Lucent Technologies. He held several positions in all technical areas – development of complex electronics, manufacturing and production and materials management. For more than 10 years Mr. Zschaeck is working in the field of medical devices. Prior to cerbomed he was quality manager of an innovative medium-sized company based in the Nuremberg area, being responsible for all product and company certifications, regulatory topics and technical specifications for internal and external partners. He is named as an inventor on 3 patents. Thomas Zschaeck holds a masters degree in Electrical Engineering.
- Dr. med. Martin Hyca
Director Marketing & SalesDr. Hyca joined cerbomed in February 2010. After his position as a physician at the German Heart Center in Munich he worked in a health care consultancy (HWP Planungsgesellschaft, Stuttgart) and has now more than 8 years experience in the medical device industry. Prior to his current job Dr. Hyca faced different positions as marketing and product manager at TomTec Imaging Systems, the market leader in 3D ultrasound imaging. As program manager he took over responsibilities in planning and leading innovation projects in the field of medical software development. Furthermore he set up a new product division (MR-imaging) and designed and implemented a new marketing oriented evaluation method for ideas and projects. Dr. Hyca holds degrees in Business Administration (MBA, focus: marketing & sales) and Medical Engineering (MSc) and received his MD and PhD in Medicine from the Ruhr University Bochum.
t-VNS provides advantages for patients. There are no surgical risks and there are only minor side effects. As patients use NEMOS autonomously, the therapy can be easily integrated into the daily routine.
Dr. Andreas Hartlep (CEO)
Do you have questions regarding NEMOS® and t-VNS® therapy? Please get in touch with us.